CA2938793C - Schema posologique de compose de fgf-18 - Google Patents

Schema posologique de compose de fgf-18

Info

Publication number
CA2938793C
CA2938793C CA2938793A CA2938793A CA2938793C CA 2938793 C CA2938793 C CA 2938793C CA 2938793 A CA2938793 A CA 2938793A CA 2938793 A CA2938793 A CA 2938793A CA 2938793 C CA2938793 C CA 2938793C
Authority
CA
Canada
Prior art keywords
fgf
compound
growth factor
fibroblast growth
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2938793A
Other languages
English (en)
Other versions
CA2938793A1 (fr
Inventor
Christoph H. Ladel
Hans Guehring
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority claimed from PCT/EP2015/053631 external-priority patent/WO2015124731A1/fr
Publication of CA2938793A1 publication Critical patent/CA2938793A1/fr
Application granted granted Critical
Publication of CA2938793C publication Critical patent/CA2938793C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Des régimes d'administration de FGF18 dans le traitement d'un trouble du cartilage, comme l'arthrose ou une blessure au cartilage, sont décrits. Les posologies peuvent comprendre la coadministration d'un médicament anti-inflammatoire.
CA2938793A 2014-02-20 2015-02-20 Schema posologique de compose de fgf-18 Active CA2938793C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14000600.8 2014-02-20
EP14000600 2014-02-20
PCT/EP2015/053631 WO2015124731A1 (fr) 2014-02-20 2015-02-20 Schéma posologique de composé de fgf-18

Publications (2)

Publication Number Publication Date
CA2938793A1 CA2938793A1 (fr) 2015-08-27
CA2938793C true CA2938793C (fr) 2026-02-17

Family

ID=

Similar Documents

Publication Publication Date Title
EP3119417B1 (fr) Régime de dosage de composé fgf-18
KR101419961B1 (ko) Ｆｇｆ-18 로 연골 질환의 치료
CA2938793C (fr) Schema posologique de compose de fgf-18
RU2745453C2 (ru) Комбинированная композиция, содержащая соединение fgf-18
HK1231895A1 (en) Fgf-18 compound dosing regimen
HK1231754A1 (zh) Fgf-18化合物给药方案
HK1129852A (en) Treatment of cartilage disorders
HK1129852B (en) Treatment of cartilage disorders